F. Karege et al., THE EFFECT OF CLINICAL OUTCOME ON PLATELET G-PROTEINS OF MAJOR DEPRESSED-PATIENTS, European neuropsychopharmacology, 8(2), 1998, pp. 89-94
Platelet G protein subunits (G alpha i2, G alpha q and G beta) were me
asured in 15 non-treated depressed patients (recurrent major depressio
n) and 15 age-and sex-matched healthy controls by using the Western im
munoblot method. The depression severity was measured by the AMDP depr
ession rating scale before start of treatment. The AMDP score ranged b
etween 12 and 44. Patients were then treated with different antidepres
sant drugs (ATD) for 1 month, after which G protein and depression wer
e reassessed. Results indicated that drug-free depressed patients disp
layed increased levels of G proteins subunits, in comparison to health
y controls. Antidepressant drug administration resulted in decrease of
depression severity but only seven patients showed a net response to
drugs (AMDP depression score less than 12), These drug-responding pati
ents have also reduced G protein levels, while patients without signif
icant improvement continued to display either the same levels of G pro
teins or higher, whatever the class of the drug administered. These re
sults suggest that depression is associated to increase in G protein s
ubunit levels and that the clinical outcome seemed to be the determini
ng factor in further decrease occurring in G protein levels. (C) 1998
Elsevier Science B.V./ECNP.